585524-80-7 Usage
General Description
4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL) CHLOROBENZENE is an organoboron compound that consists of a chlorobenzene ring attached to a boron-containing heterocycle. It is commonly used as a building block in organic synthesis, particularly in the formation of carbon-carbon and carbon-heteroatom bonds. 4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL) CHLOROBENZENE is known for its use in Suzuki-Miyaura cross-coupling reactions, which are widely used in pharmaceutical and material science research. 4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL) CHLOROBENZENE is an important intermediate in the production of various pharmaceuticals, agrochemicals, and materials with potential applications in electronics and optics. Due to its versatile reactivity and stability, it is a valuable tool for chemists working in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 585524-80-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,5,5,2 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 585524-80:
(8*5)+(7*8)+(6*5)+(5*5)+(4*2)+(3*4)+(2*8)+(1*0)=187
187 % 10 = 7
So 585524-80-7 is a valid CAS Registry Number.
585524-80-7Relevant articles and documents
Palladium-catalysed reactions of conjugated enyne oxiranes with organoborons: A diastereoselective method of the synthesis of 2,4,5-trienol derivatives
Ziyanak, F?rat,Ku?, Melih,Alkan-Karadeniz, Leman,Artok, Levent
, p. 3652 - 3662 (2018/05/25)
A palladium-catalysed reaction of conjugated enyne oxiranes with organoboron reagents is described. This method allows aryl-substituted vinylallenes containing a hydroxyl group on the allylic position to be synthesized, with good diastereomeric ratios, un
PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF
-
Page 30, (2008/06/13)
Use of compounds to inhibit hormone-sensitive lipase, the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds, method of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitve lipase and may be useful in the treatment and/or prevention of a range of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
